Unlike in the rest of the country, where intestinal ultrasound rarely is used in the clinic, in New York City, gastroenterologists at Mount Sinai Hospital have made IUS findings the “the fifth vital sign” for inflammatory bowel disease patient care, particularly to monitor disease. Now, new research from the institution and other centers is showing that the tool can identify patients with endoscopic recurrence and possibly predict disease outcomes and treatment response.
Trending
- Who Adopts AI First: Endoscopists or Humanoid Robots?
- Quest Diagnostics to offer liver cancer blood test (Becker’s GI & Endoscopy)
- Greater Scope: Doctors Get Inside Look at Gut Health With AI-Powered Endoscopy (NVIDIA)
- State of AI in Medicine (Doximity)
- Abbott Acquisition Of Exact Sciences Refocuses Growth On Cancer Diagnostics (Simply Wall Street)
- Will the ‘gestalt’ matter less in GI surgery? (Becker’s GI & Endoscopy)
- Advancing Multidisciplinary Strategies for Obesity Care (AJMC)
- 5 studies scaring gastroenterologists (Becker’s ASC Review)
